BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32487104)

  • 1. The efficacy of surgery in advanced hepatocellular carcinoma: a cohort study.
    Chen L; Sun T; Chen S; Ren Y; Yang F; Zheng C
    World J Surg Oncol; 2020 Jun; 18(1):119. PubMed ID: 32487104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of radiofrequency ablation versus cryoablation in the treatment of single hepatocellular carcinoma: A population-based study.
    Chen L; Ren Y; Sun T; Cao Y; Yan L; Zhang W; Ouyang T; Zheng C
    Cancer Med; 2021 Jun; 10(11):3715-3725. PubMed ID: 33960697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis.
    Zhao H; Chen C; Gu S; Yan X; Jia W; Mao L; Qiu Y
    J Gastroenterol Hepatol; 2017 Apr; 32(4):870-878. PubMed ID: 27671209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.
    Wang G; Zhang W; Tan Y; Jiang L; Yang J; Yang J; Yan L
    Int J Surg; 2019 Dec; 72():1-6. PubMed ID: 31610283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy of pre-surgery and post-surgery radiotherapy in the treatment of hepatocellular carcinoma: a population-based study.
    Chen L; Guo X; Chen S; Ren Y; Sun T; Yang F; Zheng C
    Am J Transl Res; 2021; 13(1):360-371. PubMed ID: 33527030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ablation alone is noninferior to radiotherapy plus ablation in the patients with early-stage hepatocellular carcinoma: a population-based study.
    Guo Y; Chen H; Wan J; Ren Y; Wu F; Chen L; Sun T; Yang L; Zheng C
    Sci Rep; 2024 Jan; 14(1):1030. PubMed ID: 38200187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgery versus external beam radiation therapy for AJCC stage I hepatocellular carcinoma.
    Han B; Shao L; Li C; Xu Y; Tang Y; Han L; Qi X
    J BUON; 2019; 24(4):1390-1401. PubMed ID: 31646782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
    Peng Z; Wei M; Chen S; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Kuang M
    Eur Radiol; 2018 Aug; 28(8):3522-3531. PubMed ID: 29536241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
    Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
    Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in Survival Between First-Line Radiofrequency Ablation versus Surgery for Early-Stage Hepatocellular Carcinoma: A Population Study Using the Surveillance, Epidemiology, and End Results Database.
    Lin Y; Pan XB
    Med Sci Monit; 2020 May; 26():e921782. PubMed ID: 32461542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative Allogeneic Blood Transfusion Does not Influence Patient Survival After Hepatectomy for Hepatocellular Carcinoma: A Propensity Score Matching Analysis.
    Yamashita YI; Hayashi H; Imai K; Okabe H; Nakagawa S; Kitamura F; Uemura N; Nakao Y; Yusa T; Itoyama R; Yamao T; Umesaki N; Miyata T; Chikamoto A; Shimokawa M; Baba H
    World J Surg; 2019 Nov; 43(11):2894-2901. PubMed ID: 31312946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysis.
    Li C; Wang MD; Lu L; Wu H; Yu JJ; Zhang WG; Pawlik TM; Zhang YM; Zhou YH; Gu WM; Wang H; Chen TH; Han J; Xing H; Li ZL; Lau WY; Wu MC; Shen F; Yang T
    Hepatol Int; 2019 Nov; 13(6):736-747. PubMed ID: 31486964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of microvascular invasion in early-intermediate stage hepatocelluar carcinoma: a propensity score matching analysis.
    Shen J; Wen J; Li C; Wen T; Yan L; Li B; Yang J; Lu C
    BMC Cancer; 2018 Mar; 18(1):278. PubMed ID: 29530006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage Hepatectomy for Recurrent Hepatocellular Carcinoma after Radiofrequency Ablation and/or Transcatheter Arterial Chemoembolization: A Propensity Score-Matched Analysis.
    Orimo T; Kamiyama T; Yokoo H; Wakayama K; Shimada S; Einama T; Kamachi H; Taketomi A
    Dig Surg; 2018; 35(5):427-434. PubMed ID: 28903105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
    Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
    Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative blood transfusion has distinct postsurgical oncologic impact on patients with different stage of hepatocellular carcinoma.
    Chen GX; Qi CY; Hu WJ; Wang XH; Hua YP; Kuang M; Peng BG; Li SQ
    BMC Cancer; 2020 May; 20(1):487. PubMed ID: 32471389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term oncologic results of anatomic vs. parenchyma-sparing resection for hepatocellular carcinoma. A propensity score-matching analysis.
    Famularo S; Di Sandro S; Giani A; Lauterio A; Sandini M; De Carlis R; Buscemi V; Romano F; Gianotti L; De Carlis L
    Eur J Surg Oncol; 2018 Oct; 44(10):1580-1587. PubMed ID: 29861336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: A propensity score-matched survival analysis.
    Gao Y; Wang PX; Cheng JW; Sun YF; Hu B; Guo W; Zhou KQ; Yin Y; Li YC; Wang J; Huang JF; Qiu SJ; Zhou J; Fan J; Yang XR
    Cancer Med; 2019 Nov; 8(16):6933-6944. PubMed ID: 31566899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between disease free survival of hepatocellular carcinoma after hepatic resection in chronic hepatitis B patients with or without cirrhosis.
    Techathuvanan K; Srisajjakul S; Pongpaibul A; Limsrichamrern S; Charatcharoenwitthaya P; Chainuvati S; Tanwandee T; Chotiyaputta W
    J Med Assoc Thai; 2015 Apr; 98(4):334-42. PubMed ID: 25958707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Efficacy of Radiotherapy in the Treatment of Hepatocellular Carcinoma with Distant Organ Metastasis.
    Chen L; Wang Z; Song S; Sun T; Ren Y; Zhang W; Wang M; Liu Y; Zheng C
    J Oncol; 2021; 2021():5190611. PubMed ID: 34840570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.